Export citation

Show simple item record

dc.contributor.authorO’Boyle, Niamh M*
dc.contributor.authorMeegan, Mary J*
dc.date.accessioned2021-02-11T08:14:55Z
dc.date.available2021-02-11T08:14:55Z
dc.date.issued2019*
dc.date.submitted2019-12-09 11:49:15*
dc.identifier42571*
dc.identifier.urihttps://directory.doabooks.org/handle/20.500.12854/40955
dc.description.abstractThe past decades have seen major developments in the understanding of the cellular and molecular biology of cancer. Significant progress has been achieved regarding long-term survival for the patients of many cancers with the use of tamoxifen for treatment of breast cancer, treatment of chronic myeloid leukaemia with imatinib, and the success of biological drugs. The transition from cytotoxic chemotherapy to targeted cancer drug discovery and development has resulted in an increasing selection of tools available to oncologists. In this Special Issue of Pharmaceuticals, we highlight the opportunities and challenges in the discovery and design of innovative cancer therapies, novel small-molecule cancer drugs and antibody–drug conjugates, with articles covering a variety of anticancer therapies and potential relevant disease states and applications. Significant efforts are being made to develop and improve cancer treatments and to translate basic research findings into clinical use, resulting in improvements in survival rates and quality of life for cancer patients. We demonstrate the possibilities and scope for future research in these areas and also highlight the challenges faced by scientists in the area of anticancer drug development leading to improved targeted treatments and better survival rates for cancer patients.*
dc.languageEnglish*
dc.subjectQD1-999*
dc.subjectQ1-390*
dc.subject.othergraphene oxide*
dc.subject.otherindole*
dc.subject.otherandrogens*
dc.subject.othercyclooxygenase-2*
dc.subject.othercyclooxygenase-1*
dc.subject.otherheteropolysaccharide*
dc.subject.otherdrug conjugation*
dc.subject.otherdrug delivery*
dc.subject.otherellipticine*
dc.subject.otherchemical linker*
dc.subject.otheroesophageal cancer*
dc.subject.otherantiproliferative activity*
dc.subject.othertopoisomerase II*
dc.subject.other?-lactam*
dc.subject.otherDSD*
dc.subject.otherantibody*
dc.subject.othertopoisomerase inhibitors*
dc.subject.othermagnetic targeting*
dc.subject.othercisplatin resistance*
dc.subject.othersteroidogenesis*
dc.subject.other[18F]FDG PET/CT*
dc.subject.otherheterocyclic chemistry*
dc.subject.otherdehydroepiandrosterone*
dc.subject.otherantimitotic*
dc.subject.other3-vinylazetidin-2-ones*
dc.subject.otherglioblastoma*
dc.subject.otherand cancer therapy*
dc.subject.otherintestinal mucositis*
dc.subject.otherCombretastatin A-4*
dc.subject.othermetabolism*
dc.subject.otheranti-cancer drugs*
dc.subject.othermaghemite*
dc.subject.otherCOX-1 inhibitor*
dc.subject.otheranticancer*
dc.subject.otherCYP17A1*
dc.subject.otherconjugate and hybrid drugs*
dc.subject.otherinflammation*
dc.subject.othersnticancer drugs*
dc.subject.otherP450c17*
dc.subject.othertumorigenesis*
dc.subject.othercisplatin*
dc.subject.otherbiomarker profiling*
dc.subject.othercancer drug design*
dc.subject.othertubulin*
dc.subject.othercytochrome P450*
dc.subject.other5-fluorouracil*
dc.subject.otherprostate cancer*
dc.subject.otherabiraterone*
dc.subject.otherNCI screen*
dc.subject.otherradiation*
dc.subject.othercancer immunotherapy*
dc.subject.othermicrotubule targeted drugs*
dc.subject.othercancer*
dc.subject.othertreatment resistance*
dc.titleAnticancer Drugs*
dc.typebook
oapen.identifier.doi10.3390/books978-3-03921-587-4*
oapen.relation.isPublishedBy46cabcaa-dd94-4bfe-87b4-55023c1b36d0*
virtual.oapen_relation_isPublishedBy.publisher_nameMDPI - Multidisciplinary Digital Publishing Institute
virtual.oapen_relation_isPublishedBy.publisher_websitewww.mdpi.com/books
oapen.relation.isbn9783039215867*
oapen.relation.isbn9783039215874*
oapen.pages214*
oapen.edition1st*


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

https://creativecommons.org/licenses/by-nc-nd/4.0/
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by-nc-nd/4.0/